4//SEC Filing
Cunningham Kenneth 4
Accession 0001104659-25-074401
CIK 0001657312other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 8:32 PM ET
Size
19.0 KB
Accession
0001104659-25-074401
Insider Transaction Report
Form 4
Cunningham Kenneth
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2025-08-01+24,000→ 90,584 total - Exercise/Conversion
Restricted Stock Units
2025-08-01−24,000→ 72,000 total→ Ordinary Shares (24,000 underlying) - Sale
Ordinary Shares
2025-08-01$13.14/sh−10,808$142,057→ 79,776 total
Footnotes (6)
- [F1]Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- [F2]The sale reported in the Form 4 represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of the restricted stock units ("RSUs").
- [F3]The price reported represents the sale price of the ADSs divided by eight (8).
- [F4]Consists of 79,776 Ordinary Shares represented by 9,972 ADSs.
- [F5]Represents an award of RSUs covering ADSs, which is presented in terms of the equivalent number of Ordinary Shares underlying the ADSs. Each RSU represents a contingent right to receive one (1) ADS of the Issuer. Each ADS represents eight (8) Ordinary Shares of the Issuer. The RSUs have no expiration date.
- [F6]The RSUs vest as to 25% of the total shares on each of August 1, 2025, November 1, 2025, February 1, 2026 and May 1, 2026 subject to the Reporting Person's continued service to the Issuer on each vesting date.
Issuer
Verona Pharma plc
CIK 0001657312
Entity typeother
Related Parties
1- filerCIK 0001836878
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 8:32 PM ET
- Size
- 19.0 KB